People discussing business charts and graphs on papers and digital devices at a wooden table, with a cup of coffee.
Close-up of a person holding a colorful molecular model, with hands wearing a white lab coat.

Explore our Featured Insights

Ours and others’ latest thinking on the issues that matter most in Advanced Therapy.

Text on a pastel pink and blue gradient background featuring mountains at the bottom. The text reads: 'hPSC-ATMP manufacture - Where are we now? HOYA'.
Title slide of a report presentation titled 'Australia Cell and Gene Therapy Landscape'. The slide also includes the subtitle 'Landscape Mapping Covering CGT Developers, GMP Manufacturers, Clinical Trials, and Regional Activities' and the author Heather Main, Principal Consultant at HOYA. The slide features a dark gradient background with white and green text.
Title page of a scientific article titled 'Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update' from Cell Stem Cell journal, with author details and a summary paragraph.

Trending Insight

“This landscape mapping provides a detailed understanding of the stakeholders, initiatives, and resources driving this sector's growth in Australia, from small companies, manufacturing facilities and clinical trials, to service and product providers. The report scopes the diversity of therapeutic platforms within Advanced Therapies, identifying Australian strengths and potential opportunities to shape the ecosystem moving forward.”

Client
Melbourne University, Australia

Year
2024

Read More

Featured Insights

Select number of insights written and co-authored by HOYA.

Person holding molecular model with colorful plastic atoms and bonds, wearing a white lab coat, vs. a plain, beige background.

Synergy in Cell Therapy Development through Mutual Respect

The model developed by Novo Nordisk, Karolinska Institutet, St Erik, and Vecura was conceptualized and implemented by Dr. Heather Main, Co-founder of HOYA.

Article
The image features a mountain range with snow-capped peaks and a pastel pink sky. The text on the image reads: 'hPSC-ATMP manufacture - Where are we now? HOYA' in large, bold letters.

hPSC-ATMP manufacture - Where are we now?

Read our first white paper on Manufacturing, the first in a series of white papers we’ve produced after conducting our pilot study with Tillväxtverket.

Author, HOYA co-founder Heather Main.

Download
Cover slide with title 'Australia Cell and Gene Therapy Landscape Report,' published in 2024, by Heather Main, Principal Consultant at HOYA. The background has a gradient from dark green to black.

Australia Cell and Gene Therapy Landscape Mapping

We’re excited to release this detailed landscape mapping report, sponsored by the University of Melbourne. It highlights the key stakeholders, clinical trials, GMP manufacturers, and more in Australia’s growing CGT ecosystem.

Download
People analyzing charts and graphs on papers and digital tablets during a business meeting, with a cup of coffee on a wooden table.

An hPSC-ATMP innovation catalyst in Sweden - pilot study

The ATMP Sweden article summarises the hPSC-ATMP Tillväxtverket pilot study and HOYA’s company formation.

Article
A scientific chart presenting data on human pluripotent stem cell (hPSC) trials, including trial initiation trends over years, cumulative trials, cell sources, trial phases, number of products and patients, trial indications for ocular, CNS, immune, cardiovascular, endocrine, and stromal categories, detailed trial indications for ocular, CNS, immune, and solid tumor, and data on average patient doses for different cell types and tissues.

Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update

The paper reviews the landscape of interventional hPSC trials worldwide, highlighting available data on clinical safety and efficacy. As of December 2024, the authors identify 115 clinical trials with regulatory approval, testing 83 hPSC products.

Read More

The Essential Guide to Virtual Data Rooms: What First-Time Founders Should Know

Navigating the startup world as a first-time founder can be overwhelming, especially when it comes to securing funding and handling sensitive data. Virtual Data Rooms (VDRs) are an invaluable tool to help streamline these processes. They offer a secure, organized way to manage documents during fundraising or due diligence, saving time and building trust with investors.

This feature will soon be added, making it easier than ever for founders to leverage VDRs for their business needs.

Coming Soon